drugset / Trial / NCT05164536
Plasma P-tau2017 and Quantitative Amyloid PET Imaging
NaSingle-groupOpen-labelOther
Summary
The overall goal of this protocol is to compare amyloid burden assessed by amyloid PET to plasma P-tau217 levels.
Timeline
- Start
- 2021-08-27
- Primary completion
- 2022-11-08
- Completion
- 2022-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir F 18 | Diagnostic / imaging agent | — | — |